Advancements in Suturing Materials: From Passive Threads to Intelligent Systems

 

Sarthak Perwal

MBBS

*Corresponding Author E-mail: perwalsarthak@gmail.com

 

Abstract:

Sutures are fundamental to surgical practice, providing mechanical support for wound closure and tissue approximation. Historically, innovations in suturing materials have focused on improving tensile strength, biocompatibility, and handling properties. However, recent advances extend far beyond mechanical function, incorporating antimicrobial activity, knotless designs, bioactive release systems, and even sensorized “smart” sutures capable of monitoring or stimulating the wound environment. This review synthesizes contemporary evidence on suturing innovations, evaluates their clinical applicability, and outlines future directions for integration into surgical practice.

 

KEYWORDS: Surgical, Sutures, Knotless, Bioactive, Wound, Environment, Biocompatibility, Evidence.

 

 


INTRODUCTION:

The surgical suture, though deceptively simple, is central to operative success. Beyond ensuring wound integrity, the suture material influences infection risk, scarring, and long-term tissue remodelling. Conventional sutures have evolved from natural fibres such as catgut and silk to synthetic absorbable and non-absorbable polymers. In recent decades, the focus has shifted towards functional sutures — materials that actively participate in wound healing rather than serving as inert foreign bodies. This review examines the state-of-the-art in suture development, highlighting clinical evidence, translational challenges, and foreseeable future applications.

 

Antimicrobial Sutures:

The most clinically established innovation is the antimicrobial-coated suture, particularly triclosan-impregnated polyglactin 910. Multiple randomized controlled trials and meta-analyses demonstrate that triclosan-coated sutures reduce surgical site infections (SSI) in a range of procedures, particularly in clean-contaminated wounds and high-risk abdominal closures1,2. Despite occasional conflicting reports, the overall body of evidence supports their incorporation into practice. The adoption of antimicrobial sutures aligns with global strategies to reduce SSI-related morbidity and healthcare costs, although judicious use is warranted to balance benefits with antimicrobial stewardship.

 

Knotless and Barbed Sutures:

Barbed sutures represent another practical advancement, designed to distribute tension evenly and eliminate the need for knots. Systematic reviews confirm that barbed sutures reduce operative time while maintaining comparable or superior wound integrity in soft tissue and gynecological procedures3,4. However, unique complications — including tissue tearing or unintended tissue entrapment — necessitate careful case selection and adequate surgeon training. In the appropriate context, barbed sutures enhance operative efficiency without compromising safety.

 

Shape-Memory and Smart Sutures:

Emerging research explores polymers with shape-memory properties capable of altering stiffness or tension in response to physiological stimuli5. These materials could sustain wound approximation dynamically, adapting as tissues remodel. Parallel developments in “smart” sutures incorporate biosensors or electronic circuits directly into suture filaments. Preclinical studies report sutures integrated with wireless strain sensors, enabling real-time monitoring of wound tension, tendon healing, or vascular patency6. Biodegradable sutures capable of generating low-level electric fields during movement have demonstrated accelerated healing and antibacterial effects in animal models, with early clinical translation underway7. While promising, these technologies remain experimental and require validation of long-term safety, degradation kinetics, and sterilization compatibility.

 

Bioactive and Nanostructured Sutures:

Biofunctionalization of sutures with nanoparticles, drug reservoirs, or electrospun nanofiber coatings represents another expanding frontier. These designs permit controlled release of antimicrobials, anti-inflammatory agents, or growth factors in a temporally programmed manner8. Such sutures could play a pivotal role in managing chronic wounds, contaminated surgical fields, or reconstructive procedures requiring enhanced regenerative capacity. Regulatory approval, however, will demand robust pharmacokinetic data and clinical validation.

 

Challenges in Translation:

Despite impressive laboratory and preclinical progress, several challenges constrain widespread clinical adoption of advanced sutures. These include:

1.     Evidence Requirements: high-quality randomized controlled trials remain the gold standard for integration into guidelines.

2.     Sterilization Compatibility: electronic or drug-eluting systems must retain function after sterilization.

3.     Biocompatibility and Degradation Predictability: polymer degradation must align with tissue healing rates.

4.     Cost-Effectiveness: premium materials must demonstrably reduce complications or hospital stay.

5.     Training and Technique Adaptation: innovations such as barbed or sensorized sutures demand refined handling skills.

 

Future Directions:

In the near term (1–3 years), wider adoption of antimicrobial and barbed sutures is expected as evidence consolidates. Over the mid-term horizon (3–7 years), sensor-integrated and stimulatory sutures may emerge for niche applications in Orthopedics and vascular surgery. Long-term visions (>7 years) envision multifunctional sutures as platforms for integrated wound management — capable of monitoring, signalling, and therapeutically intervening.

 

CONCLUSION:

The evolution of suturing materials reflects a paradigm shift from passive mechanical support to active biological and electronic engagement with the wound environment. While antimicrobial and barbed sutures already have established clinical utility, emerging technologies such as smart sutures and bioactive materials hold transformative potential. Surgeons must critically evaluate these innovations, balancing enthusiasm with evidence, to ensure that novel sutures achieve their promise of improving surgical outcomes.

 

REFERENCES:

1.        Jalalzadeh H, et al. Triclosan-Containing Sutures for the Prevention of Surgical Site Infection: A Systematic Review and Meta-Analysis. (2025).

2.        Edwards M, et al. Sutures for Preventing Surgical Site Infection: A Systematic Review. (2023).

3.        Gupta N, et al. Barbed Sutures in Soft Tissue Closure: A Systematic Review. (2023).

4.        Varela JE, et al. Efficacy of Barbed Sutures in Laparoscopic Surgery. (2022).

5.        Pisani S, et al. Shape-Memory Polymers: Biomedical Applications. (2023).

6.        Yang G, et al. Implantable Wireless Suture Sensor for In Situ Tendon and Tissue Monitoring. (2025).

7.        Zhang X, et al. Biodegradable Self-Electrifying Sutures for Enhanced Healing. (2024).

8.        Li Y, et al. Advances, Challenges, and Prospects for Surgical Suture Materials. (2023).

 

 

 

Received on 01.10.2025      Revised on 25.11.2025

Accepted on 28.12.2025      Published on 14.02.2026

Available online from February 18, 2026

Research J. Science and Tech. 2026; 18(1):90-92.

DOI: 10.52711/2349-2988.2026.00013

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.